Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Opinion Fellow Talk

My Picks for Fellows Attending TCT 2016

Ankur Kalra

October 27, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2016

Shelley Wood

September 30, 2016

News Daily News

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

Yael L. Maxwell

August 03, 2016

News Daily News

Decline Seen in Readmissions After PCI in the Medicare Population

Todd Neale

July 21, 2016

News Conference News TCT 2015

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

October 13, 2015

News Conference News TCT 2015

Discussion Highlights Merits, Limitations of Small Trials

Yael L. Maxwell

October 13, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

News Features

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

July 28, 2015

News Daily News

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

L.A. McKeown

July 01, 2015

News Daily News

Long-term Ticagrelor Therapy Cost-Effective in US Patients

L.A. McKeown

February 02, 2015

News Daily News

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Todd Neale

January 28, 2015

News Daily News

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

L.A. McKeown

August 07, 2014

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Daily News

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

Yael L. Maxwell

July 11, 2012

News Conference News

PRISM Individualized Informed Consent Improves PCI Choice, Experience

November 14, 2011

News Daily News

Researchers Accurately Predict Who Will Discontinue Clopidogrel

Jason Kahn

January 09, 2011

Advertisement

My Picks for Fellows Attending TCT 2016

TCTMD’s Top 10 Most Popular Stories for September 2016

Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI

Decline Seen in Readmissions After PCI in the Medicare Population

Safety, Efficacy Endpoints Must Be Balanced in Clinical Trials

Discussion Highlights Merits, Limitations of Small Trials

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Opportunities Exist for Hospitals, Interventionalists to Stave Off Unnecessary Readmissions

RIBS IV: EES Surpass DCB for Treatment of In-Stent Restenosis

Long-term Ticagrelor Therapy Cost-Effective in US Patients

HF Worsens Outcomes Following ACS, With No Benefit From Apixaban

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

Innovation in Intervention: Perspectives from Industry

Halving DES Use in Low-Risk Patients Could Save $200 Million Annually

PRISM Individualized Informed Consent Improves PCI Choice, Experience

Researchers Accurately Predict Who Will Discontinue Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content